|
1
|
Govindan R, Page N, Morgensztern D, Read
W, Tierney R, Vlahiotis A, Spitznagel EL and Piccirillo J: Changing
epidemiology of small-cell lung cancer in the United States over
the last 30 years: Analysis of the surveillance, epidemiologic, and
end results database. J Clin Oncol. 24:4539–4544. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Manapov F, Käsmann L, Roengvoraphoj O,
Dantes M, Schmidt-Hegemann NS, Belka C and Eze C: Prophylactic
cranial irradiation in small-cell lung cancer: Update on patient
selection, efficacy and outcomes. Lung Cancer (Auckl). 9:49–55.
2018.PubMed/NCBI
|
|
3
|
Alexopoulos CG, Vaslamatzis M, Patilla E
and Taranto L: Central nervous system involvement and the role of
prophylactic cranial irradiation in small cell lung cancer.
Oncologist. 2:153–159. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arriagada R, Le Chevalier T, Borie F,
Rivière A, Chomy P, Monnet I, Tardivon A, Viader F, Tarayre M and
Benhamou S: Prophylactic cranial irradiation for patients with
small-cell lung cancer in complete remission. J Natl Cancer Inst.
87:183–190. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Elliott JA, Osterlind K, Hirsch FR and
Hansen HH: Metastatic patterns in small-cell lung cancer:
Correlation of autopsy findings with clinical parameters in 537
patients. J Clin Oncol. 5:246–254. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aupérin A, Arriagada R, Pignon JP, Le
Péchoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka
H, Wagner H and Aisner J: Prophylactic cranial irradiation for
patients with small-cell lung cancer in complete remission.
Prophylactic cranial irradiation overview collaborative group. N
Engl J Med. 341:476–484. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
National Comprehensive Cancer Network, .
Clinical practice guide-lines in oncology: small cell lung cancer
(version 1). 2022.https://www.nccn.org/professionals/physician_gls/default.aspx#sclc
|
|
8
|
Meert AP, Paesmans M, Berghmans T, Martin
B, Mascaux C, Vallot F, Verdebout JM, Lafitte JJ and Sculier JP:
Prophylactic cranial irradiation in small cell lung cancer: A
systematic review of the literature with meta-analysis. BMC Cancer.
1:52001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seute T, Leffers P, ten Velde GP and
Twijnstra A: Detection of brain metastases from small cell lung
cancer: Consequences of changing imaging techniques (CT versus
MRI). Cancer. 112:1827–1834. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, Wang Y, Ren F, Huang Z, Tan B,
Zhao Z, Yu X, Dong P, Yu J and Meng X: Prophylactic cranial
irradiation (PCI) versus active surveillance in patients with
limited-stage small cell lung cancer: A retrospective, multicentre
study. Respir Res. 23:2742022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eze C, Roengvoraphoj O, Niyazi M,
Hildebrandt G, Fietkau R, Belka C and Manapov F: Treatment response
and prophylactic cranial irradiation are prognostic factors in a
real-life limited-disease small-cell lung cancer patient cohort
comprehensively staged with cranial magnetic resonance imaging.
Clin Lung Cancer. 18:e243–e249. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Inoue Y, Tsujino K, Sulaiman NS, Marudai
M, Kajihara A, Miyazaki S, Sekii S, Uezono H, Ota Y and Soejima T:
Re-evaluation of prophylactic cranial irradiation in limited-stage
small cell lung cancer: A propensity score matched analysis. J
Radiat Res. 62:877–883. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu H, Guo H, Shi F, Zhu K, Luo J, Liu X,
Kong L and Yu J: Prophylactic cranial irradiation improved the
overall survival of patients with surgically resected small cell
lung cancer, but not for stage I disease. Lung Cancer. 86:334–338.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Ding C, Yang C, Wang S and Qiao X:
Prophylactic cranial irradiation confers favourable prognosis for
patients with limited-stage small cell lung cancer in the era of
MRI: A propensity score-matched analysis. J Med Imaging Radiat
Oncol. 65:778–785. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mamesaya N, Wakuda K, Omae K, Miyawaki E,
Kotake M, Fujiwara T, Kawamura T, Kobayashi H, Nakashima K, Omori
S, et al: Efficacy of prophylactic cranial irradiation in patients
with limited-disease small-cell lung cancer who were confirmed to
have no brain metastasis via magnetic resonance imaging after
initial chemoradiotherapy. Oncotarget. 9:17664–17674. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ozawa Y, Omae M, Fujii M, Matsui T, Kato
M, Sagisaka S, Asada K, Karayama M, Shirai T, Yasuda K, et al:
Management of brain metastasis with magnetic resonance imaging and
stereotactic irradiation attenuated benefits of prophylactic
cranial irradiation in patients with limited-stage small cell lung
cancer. BMC Cancer. 15:5892015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pan L, Fan X, Wang L, Wang Y, Li Y, Cui Y,
Zheng H, Yi Q and Wu K: Prophylactic cranial irradiation for
limited-stage small-cell lung cancer in the magnetic resonance
imaging era. Cancer Med. 12:2484–2492. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qi C, Li W, Li H, Wen F, Zhou L, Sun X and
Yu H: Benefits of prophylactic cranial irradiation in the MRI era
for patients with limited stage small cell lung cancer. Front
Oncol. 12:8334782022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ghanta S, Keller A, Rodríguez-López JL,
Patel A and Beriwal S: Utility of prophylactic cranial irradiation
for limited stage small cell lung cancer in the modern era with
magnetic resonance imaging surveillance. Clin Oncol (R Coll
Radiol). 33:e323–e330. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pezzi TA, Fang P, Gjyshi O, Feng L, Liu S,
Komaki R and Lin SH: Rates of overall survival and intracranial
control in the magnetic resonance imaging era for patients with
limited-stage small cell lung cancer with and without prophylactic
cranial irradiation. JAMA Netw Open. 3:e2019292020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Farooqi AS, Holliday EB, Allen PK, Wei X,
Cox JD and Komaki R: Prophylactic cranial irradiation after
definitive chemoradiotherapy for limited-stage small cell lung
cancer: Do all patients benefit? Radiother Oncol. 122:307–312.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sas-Korczyńska B, Łuczyńska E, Kamzol W
and Sokołowski A: Analysis of risk factors for pulmonary
complications in patients with limited-stage small cell lung
cancer: A single-centre retrospective study. Strahlenther Onkol.
193:141–149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen MY, Hu X, Xu YJ and Chen M: The
impact of prophylactic cranial irradiation for post-operative
patients with limited stage small cell lung cancer. Medicine
(Baltimore). 97:e130292018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim TG, Pyo H, Ahn YC, Noh JM and Oh D:
Role of prophylactic cranial irradiation for elderly patients with
limited-disease small-cell lung cancer: Inverse probability of
treatment weighting using propensity score. J Radiat Res.
60:630–638. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee TH, Chung JH, Wu HG, Kim S, Lee JH,
Keam B, Kim JS, Kim KH, Kim BH and Kim HJ: Efficacy of prophylactic
cranial irradiation according to the risk of extracranial
recurrence in limited-stage small cell lung cancer. Cancer Res
Treat. 55:875–884. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Farris MK, Wheless WH, Hughes RT, Soike
MH, Masters AH, Helis CA, Chan MD, Cramer CK, Ruiz J, Lycan T, et
al: Limited-stage small cell lung cancer: Is prophylactic cranial
irradiation necessary? Pract Radiat Oncol. 9:e599–e607. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yin K, Song D, Zhang H, Cai F, Chen J and
Dang J: Efficacy of surgery and prophylactic cranial irradiation in
stage II and III small cell lung cancer. J Cancer. 9:3500–3506.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Held MK, Hansen O, Schytte T, Hansen KH,
Bahij R, Nielsen M, Nielsen TB and Jeppesen SS: Outcomes of
prophylactic cranial irradiation in patients with small cell lung
cancer in the modern era of baseline magnetic resonance imaging of
the brain. Acta Oncol. 61:185–192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lim YJ, Song C and Kim HJ; Korean
Association for Lung Cancer and Korea Central Cancer Registry, :
survival impact of prophylactic cranial irradiation in small-cell
lung cancer in the modern era of magnetic resonance imaging
staging. Radiat Oncol. 17:262022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jeong JU, Jeon W, Ahn SJ, Kim YC, Oh IJ,
Park CK, Yoon MS, Song JY, Nam TK and Chung WK: Treatment time to
the end of thoracic radiotherapy has more predictive power for
survival than radiation dose intensity in patients with
limited-stage small-cell lung cancer receiving concurrent
chemoradiation of more than 45 Gy. Oncol Lett. 19:239–246.
2020.PubMed/NCBI
|
|
31
|
Cook DA and Reed DA: Appraising the
quality of medical education research methods: The medical
education research study quality instrument and the
newcastle-ottawa scale-education. Acad Med. 90:1067–1076. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tierney JF, Stewart LA, Ghersi D, Burdett
S and Sydes MR: Practical methods for incorporating summary
time-to-event data into meta-analysis. Trials. 8:162007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Higgins JPT, Thomas J, Chandler J,
Cumpston M, Li T, Page MJ and Welch VA: Cochrane handbook for
systematic reviews of interventions version 6.5 (updated August
2024). Cochrane; 2024, Available from. www.training.cochrane.org/handbook
|
|
34
|
Manapov F, Klautke G and Fietkau R:
Prevalence of brain metastases immediately before prophylactic
cranial irradiation in limited disease small cell lung cancer
patients with complete remission to chemoradiotherapy: A single
institution experience. J Thorac Oncol. 3:652–655. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chi C, Wang C, Dong L, Li X and Xu L:
Prophylactic cranial irradiation in limited-stage small cell lung
cancer: A meta-analysis. J Coll Physicians Surg Pak. 34:461–467.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu J, Shen B, Yang Y, Guo J, Ren W, Zhou
Q, Mao J, Ye W and Wu D: Survival benefit of prophylactic cranial
irradiation in limited-stage small-cell lung cancer in modern
magnetic resonance imaging staging: A systematic review and
meta-analysis. Acta Oncol. 62:305–314. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takahashi T, Yamanaka T, Seto T, Harada H,
Nokihara H, Saka H, Nishio M, Kaneda H, Takayama K, Ishimoto O, et
al: Prophylactic cranial irradiation versus observation in patients
with extensive-disease small-cell lung cancer: A multicentre,
randomised, open-label, phase 3 trial. Lancet Oncol. 18:663–671.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Levy A, Rusthoven CG, Brown PD, Le Péchoux
C and Faivre-Finn C: Prophylactic cranial irradiation for patients
with SCLC-A new perspective in the immunotherapy era. J Thorac
Oncol. 15:S1556-0864-02446-8. 2024.
|
|
39
|
Levy A, Berghmans T, Koller M, Fournier B,
Mauer M, Andratschke N and Faivre-Finn C: PRIMALung (EORTC-1901):
PRophylactic cerebral irradiation (PCI) or active brain MAgnetic
resonance imaging (MRI) surveillance in small-cell lung cancer
(SCLC) patients. Lung Cancer. 198:1079932024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
S1827 (MAVERICK) Testing whether the use
of brain scans alone instead of brain scans plus preventive brain
radiation affects lifespan in patients with small cell lung cancer.
https://clinicaltrials.gov/study/NCT04155034
|
|
41
|
Ellis PM, Swaminath A and Pond GR:
Patterns of relapse in small cell lung cancer: Competing risks of
thoracic versus CNS relapse. Curr Oncol. 28:2778–2788. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
David RS, Ying C, Byoung CC, Laktionov KK,
Fang J, Chen Y, Zenke Y, Lee KH, Wang Q, Navarro A, et al:
ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for
patients (pts) with limited-stage small-cell lung cancer (LS-SCLC).
ASCO; LBA5: 2024
|
|
43
|
Welsh JW, Heymach JV, Guo C, Menon H,
Klein K, Cushman TR, Verma V, Hess KR, Shroff G, Tang C, et al:
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation
Therapy for Limited-Stage SCLC. J Thorac Oncol. 15:1919–1927. 2020.
View Article : Google Scholar : PubMed/NCBI
|
